This topic contains a solution. Click here to go to the answer

Author Question: The current generation of ERP systems does not work well with ________ architecture on legacy ... (Read 106 times)

Alainaaa8

  • Hero Member
  • *****
  • Posts: 576
The current generation of ERP systems does not work well with ________ architecture on legacy platforms.
 
  A) in-house
  B) distributed
  C) grid
  D) centralized
  E) cross-platform

Question 2

The SDLC provides a systematic process for planning, ________, and creating an information system for organizations.
 
  A) designing
  B) purchasing
  C) managing
  D) financing
  E) visualizing



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

flannelavenger

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

D

Answer to Question 2

A




Alainaaa8

  • Member
  • Posts: 576
Reply 2 on: Jul 7, 2018
Great answer, keep it coming :)


phuda

  • Member
  • Posts: 348
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

Opium has influenced much of the world's most popular literature. The following authors were all opium users, of varying degrees: Lewis Carroll, Charles, Dickens, Arthur Conan Doyle, and Oscar Wilde.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library